TABLE 2 Providing paediatric HIV care and treatment Estimated number of children (aged 0–14) living with HIV, 2012
Countries and areas
TOWARDS AN AIDS-FREE GENERATION – Children and AIDS: Sixth Stocktaking Report, 2013
The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Yemen Zambia Zimbabwe
Estimate
Low
Estimated number of pregnant women living with HIV, 2012
High
Low
High
Number of infants born to pregnant women living with HIV started on antiretroviral prophylaxis to prevent mother-to-child transmission, 2012
–
–
–
–
–
–
0
–
–
–
–
– 17,000 – – – – – – 190,000 – – –
– 14,000 – – – – – – 160,000 – – –
– 21,000 – – – – – – 230,000 – – –
– 5,100 – – – – – – 100,000 – – –
– 4,200 – <500 <100 <100 – – 88,000 2,000 – <1,000
– 6,300 – <500 <100 <200 – – 120,000 3,900 – 1,100
– 2,476 – – 0 – – – – – – –
– 48 – – – – – – – – – –
– 39 – – <1 – – – – – – –
– 59 – – <1 – – – – – – –
– 2,982 – – 5 2 – – – – – –
230,000
200,000
270,000
97,000
83,000
110,000
48,858
51
44
59
71,571
– – – –
– – – –
– – – –
– – – –
3,200 <100 <500 –
11,000 <200 <1,000 –
– – – 1
– – – –
– – – –
– – – –
– – 521 1
–
–
–
–
1,000
2,700
–
–
–
–
–
– – 160,000 180,000
– – 140,000 160,000
– – 170,000 200,000
– – 79,000 68,000
<1,000 <500 71,000 60,000
6,200 2,400 88,000 76,000
1,342 7 41,095 36,711
– – 52 54
21 <1 46 48
>95 2 58 61
1,822 17 34,062 51,566
2,700,000
3,300,000
1,400,000
1,200,000
1,500,000
478,432
44
39
50
618,518
2,000,000
2,400,000
1,000,000
940,000
1,100,000
447,788
56
50
64
573,292
730,000
990,000
350,000
300,000
400,000
30,644
10
9
12
45,204
9,800
23,000
6,700
4,600
10,000
285
9
5
17
347
140,000 41,000
210,000 94,000
39,000 36,000
32,000 24,000
57,000 53,000
86 6,140
3 27
1 18
5 41
13,588 14,653
46,000
70,000
24,000
19,000
33,000
4,947
43
30
58
16,458
17,000
24,000
13,000
9,000
17,000
774
69
42
>95
1,599
1,400,000
1,800,000
640,000
580,000
730,000
159,451
41
34
48
189,631
3,000,000
3,700,000
1,500,000
1,300,000
1,600,000
490,664
44
38
50
665,304
3,000,000
3,700,000
1,500,000
1,400,000
1,700,000
–
–
–
–
–
SUMMARY INDICATORS Sub-Saharan Africaa/ 3,000,000 Eastern and 2,100,000 Southern Africa West and Central Africa 860,000 Middle East and 14,000 North Africa South Asia 150,000 East Asia and the Pacific 63,000 Latin America and 56,000 the Caribbean CEE/CIS 19,000 Least developed 1,500,000 countries Low- and middle3,200,000 income countries World 3,300,000
DEFINITIONS OF THE INDICATORS
Estimated number of children (aged 0–14) living with HIV, 2012: Estimated number of children (aged 0–14) living with HIV as of 2012. Estimated number of pregnant women living with HIV, 2012: Estimated number of pregnant women living with HIV as of 2012. Number of infants born to pregnant women living with HIV started on cotrimoxazole prophylaxis, 2012: Reported number of HIV-exposed infants (those born to HIV-positive mothers) started on cotrimoxazole prophylaxis within two months of birth. Percentage of infants born to pregnant women living with HIV started on cotrimoxazole prophylaxis, 2012: Calculated by dividing the number of HIV-exposed infants started on cotrimoxazole prophylaxis by the estimated number of children born to pregnant women living with HIV. The denominator is the estimated unrounded number of pregnant women living with HIV as of 2012. Number of infants born to pregnant women living with HIV started on antiretroviral prophylaxis to prevent motherto-child transmission, 2012: Reported number of HIV-exposed 64
Estimate
Number of infants born to pregnant women % of infants born to pregnant living with HIV started women living with HIV on cotrimoxazole started on cotrimoxazole prophylaxis, 2012 prophylaxis, 2012
infants given antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV as of 2012. Percentage of infants born to pregnant women living with HIV started on antiretroviral prophylaxis to prevent mother-to-child transmission, 2012: Calculated by dividing the number of HIV-exposed infants given antiretroviral prophylaxis by the estimated number of children born to pregnant women living with HIV. The denominator is the estimated unrounded number of pregnant women living with HIV as of 2012. Number of infants born to pregnant women living with HIV receiving virological test for HIV within two months of birth, 2012: Reported number of HIV-exposed infants receiving a virological HIV test within two months of birth. Percentage of infants born to pregnant women living with HIV receiving virological test for HIV within two months of birth, 2012: Calculated by dividing the number of HIV-exposed infants receiving a virological HIV test by the estimated number of children born to pregnant women living with HIV. The denominator is the estimated unrounded number of pregnant women living with HIV as of 2012. Estimated number of children needing antiretroviral therapy based on UNAIDS/WHO guidelines, 2012:
Estimated number of children (aged 0–14) living with HIV in need of antiretroviral treatment (ART) as of 2012. Number of children (aged 0–14) receiving antiretroviral therapy, 2012: Reported number of children (aged 0–14) living with HIV receiving ART as of 2012. Estimated antiretroviral therapy coverage among children (aged 0–14), %, 2012: Calculated by dividing the reported number of children (aged 0–14) receiving ART by the estimated number of children (aged 0–14) in need of ART as 2012.
MAIN DATA SOURCES
Estimated number of children (aged 0–14) living with HIV, 2012: Joint United Nations Programme on HIV/AIDS, Global Report: UNAIDS report on the global AIDS epidemic 2013, UNAIDS, Geneva, 2013. Estimated number of pregnant women living with HIV, 2012: Joint United Nations Programme on HIV/AIDS, Global Report: UNAIDS report on the global AIDS epidemic 2013, UNAIDS, Geneva, 2013. Number of infants born to pregnant women living with HIV started on cotrimoxazole prophylaxis, 2012: UNAIDS, UNICEF, WHO, 2013 Global AIDS Response Progress Reporting.